54
Growth Score
pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1057664
Xinnate is a biotech firm that develops peptide-based drugs for the prevention and treatment of inflammatory diseases.
- Helene Hartman: Co-Founder, Chief Executive Officer
- Artur Schmidtchen: Co-Founder, CMO/Inventor
About the Company
Xinnate is a biopharmaceutical company built on academic research on biological systems that have evolved to maintain community health along with intrinsic defense and healing capabilities. For the prevention and treatment of inflammatory illnesses and infections in the context of skin and wounds, surgical materials, and biomaterials, they
concentrate on the creation of patented peptide-based medications. They deliver hydrogel, the BioC wound gel developed for burn wound treatment.
